Wendland G - Search Results

1

[Coronary disease and social security. A simulation model on cost analysis].

Hinzpeter B, Klever-Deichert G, Wendland G, Lauterbach KW. Hinzpeter B, et al. Among authors: wendland g. Herz. 2000 Aug;25(5):515-25. doi: 10.1007/pl00001964. Herz. 2000. PMID: 10993000 German.

2

[Cost-benefit analysis of an evidence-based secondary prevention of coronary heart diseases by statins. An analysis for Germany from a social security perspective].

Klever-Deichert G, Hinzpeter B, Wendland G, Lauterbach K. Klever-Deichert G, et al. Among authors: wendland g. Med Klin (Munich). 2000 Jun 15;95(6):305-13. doi: 10.1007/pl00002127. Med Klin (Munich). 2000. PMID: 10935414 German.

3

[Stent implantation as initial coronary interventional therapy? A theoretical model on clinical and economical consequences of in-stent restenosis].

Pfund A, Wendland G, Baer F, Lauterbach K, Höpp HW. Pfund A, et al. Among authors: wendland g. Herz. 2000 Aug;25(5):495-501. doi: 10.1007/pl00001962. Herz. 2000. PMID: 10992998 German.

4

[Cost effectiveness of lipid lowering therapy].

Wendland G, Klever-Deichert G, Lauterbach K. Wendland G, et al. Herz. 2001 Dec;26(8):552-60. doi: 10.1007/pl00002059. Herz. 2001. PMID: 11820158 German.

5

[Cost-effectiveness of coronary heart disease prevention].

Wendland G, Klever-Deichert G, Lauterbach K. Wendland G, et al. Z Kardiol. 2002;91 Suppl 2:49-60. Z Kardiol. 2002. PMID: 12436765 Review. German.

6

Asthma: prevalence and cost of illness.

Stock S, Redaelli M, Luengen M, Wendland G, Civello D, Lauterbach KW. Stock S, et al. Among authors: wendland g. Eur Respir J. 2005 Jan;25(1):47-53. doi: 10.1183/09031936.04.00116203. Eur Respir J. 2005. PMID: 15640322 Free article.

7

Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany.

Stock SA, Redaelli M, Wendland G, Civello D, Lauterbach KW. Stock SA, et al. Among authors: wendland g. Diabet Med. 2006 Mar;23(3):299-305. doi: 10.1111/j.1464-5491.2005.01779.x. Diabet Med. 2006. PMID: 16492214

8

[Coronary intervention and occupational rehabilitation--a prospective, randomized intervention study].

Pfund A, Pütz J, Wendland G, Theisson M, Aydin U, Hinzpeter B, Lauterbach K, Pöhler E, Höpp HW. Pfund A, et al. Among authors: wendland g. Z Kardiol. 2001 Sep;90(9):655-60. doi: 10.1007/s003920170113. Z Kardiol. 2001. PMID: 11677802 Clinical Trial. German.

9

Effectiveness of the glycoprotein IIb/IIIa antagonist abciximab during percutaneous coronary interventions (PCI) in clinical practice at a single high-volume center.

Zahn R, Fraiture B, Siegler KE, Schneider S, Gitt AK, Seidl K, Gandjour A, Wendland G, Vogt S, Lauterbach KW, Senges J. Zahn R, et al. Among authors: wendland g. Z Kardiol. 2003 Jun;92(6):438-44. doi: 10.1007/s00392-003-0928-1. Z Kardiol. 2003. PMID: 12819992

10

Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study.

Hauner H, Meier M, Wendland G, Kurscheid T, Lauterbach K; Study Group SA; SAT Study. Hauner H, et al. Among authors: wendland g. Exp Clin Endocrinol Diabetes. 2004 Apr;112(4):201-7. doi: 10.1055/s-2004-817934. Exp Clin Endocrinol Diabetes. 2004. PMID: 15127325 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters